PTEN deletion is rare but often homogeneous in gastric cancer.
Beteiligte Einrichtungen
Abstract
Gastric carcinoma is the second most frequent cause of cancer-related death worldwide. As PTEN is a potential modifier of tumour response to trastuzumab, a recently approved therapy in metastatic HER2 positive gastric cancer, the existence of PTEN deletions in primary gastric cancer was investigated.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | 8 |
| ISSN | 0021-9746 |
| Status | Veröffentlicht - 2012 |
| pubmed | 22639407 |
|---|
